The emerging roles of bacterial proteases in intestinal diseases

References

• Hedstrom L. Serine protease mechanism and specificity. Chem Rev. 2002;102:4501–21. doi:10.1021/cr000033x.
   PubMed Web of Science ®Google Scholar
• Di Cera E. Serine proteases. IUBMB Life. 2009;61:510–515. doi:10.1002/iub.186.
   PubMed Web of Science ®Google Scholar
• Sukharev SA, Pleshakova OV, Sadovnikov VB. Role of proteases in activation of apoptosis. Cell Death Differ. 1997;4:457–462. doi:10.1038/sj.cdd.4400263.
   PubMed Web of Science ®Google Scholar
• Suresh B, Lee J, Kim H, Ramakrishna S. Regulation of pluripotency and differentiation by deubiquitinating enzymes. Cell Death Differ. 2016;23:1257–1264. doi:10.1038/cdd.2016.53.
   PubMed Web of Science ®Google Scholar
• Perisic Nanut M, Pecar Fonovic U, Jakos T, Kos J. The role of cysteine peptidases in hematopoietic stem cell differentiation and modulation of immune system function. Front Immunol. 2021;12:680279. doi:10.3389/fimmu.2021.680279.
   PubMed Web of Science ®Google Scholar
• Kong W, McConalogue K, Khitin LM, Hollenberg MD, Payan DG, Bohm SK, Bunnett NW. Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc Natl Acad Sci U S A. 1997;94(16):8884–8889. doi:10.1073/pnas.94.16.8884.
   PubMed Web of Science ®Google Scholar
• Rolland-Fourcade C, Denadai-Souza A, Cirillo C, Lopez C, Jaramillo JO, Desormeaux C, Cenac N, Motta J-P, Larauche M, Taché Y, et al. Epithelial expression and function of trypsin-3 in irritable bowel syndrome. Gut. 2017;66:1767–1778. doi:10.1136/gutjnl-2016-312094.
   PubMed Web of Science ®Google Scholar
• Denadai-Souza A, Bonnart C, Tapias NS, Marcellin M, Gilmore B, Alric L, Bonnet D, Burlet-Schiltz O, Hollenberg MD, Vergnolle N, et al. Functional proteomic profiling of secreted serine proteases in health and inflammatory bowel disease. Sci Rep. 2018;8:7834. doi:10.1038/s41598-018-26282-y.
   PubMed Web of Science ®Google Scholar
• Li Y, Watanabe E, Kawashima Y, Plichta DR, Wang Z, Ujike M, et al. Identification of trypsin-degrading commensals in the large intestine. Nature. 2022;609(7927):582-589. doi: 10.1038/s41586-022-05181-3.
   Web of Science ®Google Scholar
• Benitez JA, Silva AJ. Vibrio cholerae hemagglutinin(HA)/protease: an extracellular metalloprotease with multiple pathogenic activities. Toxicon. 2016;115:55–62. doi:10.1016/j.toxicon.2016.03.003.
   PubMed Web of Science ®Google Scholar
• Frees D, Brondsted L, Ingmer H. Bacterial proteases and virulence. Subcell Biochem. 2013;66:161–192.
   PubMedGoogle Scholar
• Jablaoui A, Kriaa A, Mkaouar H, Akermi N, Soussou S, Wysocka M, Wołoszyn D, Amouri A, Gargouri A, Maguin E, et al. Fecal Serine Protease Profiling in Inflammatory Bowel Diseases. Front Cell Infect Microbiol. 2020;10:21. doi:10.3389/fcimb.2020.00021.
   PubMed Web of Science ®Google Scholar
• Edogawa S, Edwinson AL, Peters SA, Chikkamenahalli LL, Sundt W, Graves S, Gurunathan SV, Breen-Lyles M, Johnson S, Dyer R, et al. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS. Gut. 2020;69:62–73. doi:10.1136/gutjnl-2018-317416.
   PubMed Web of Science ®Google Scholar
• Goodwin S, McPherson JD, McCombie WR. Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet. 2016;17:333–351. doi:10.1038/nrg.2016.49.
   PubMed Web of Science ®Google Scholar
• Bauermeister A, Mannochio-Russo H, Costa-Lotufo LV, Jarmusch AK, Dorrestein PC. Mass spectrometry-based metabolomics in microbiome investigations. Nat Rev Microbiol. 2022;20:143–160. doi:10.1038/s41579-021-00621-9.
   PubMed Web of Science ®Google Scholar
• Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 2018;10(472):eaap8914. doi: 10.1126/scitranslmed.aap8914.
   Web of Science ®Google Scholar
• Metwaly A, Dunkel A, Waldschmitt N, Raj ACD, Lagkouvardos I, Corraliza AM, Mayorgas A, Martinez-Medina M, Reiter S, Schloter M, et al. Integrated microbiota and metabolite profiles link Crohn’s disease to sulfur metabolism. Nat Commun. 2020;11(1):4322. doi:10.1038/s41467-020-17956-1.
   PubMed Web of Science ®Google Scholar
• Caminero A, McCarville JL, Galipeau HJ, Deraison C, Bernier SP, Constante M, Rolland C, Meisel M, Murray JA, Yu XB, et al. Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2. Nat Commun. 2019;10(1):1198. doi:10.1038/s41467-019-09037-9.
   PubMed Web of Science ®Google Scholar
• Sessenwein JL, Baker CC, Pradhananga S, Maitland ME, Petrof EO, Allen-Vercoe E, Noordhof C, Reed DE, Vanner SJ, Lomax AE, et al. Protease-Mediated suppression of DRG neuron excitability by commensal bacteria. J Neurosci. 2017;37(48):11758–11768. doi:10.1523/JNEUROSCI.1672-17.2017.
   PubMed Web of Science ®Google Scholar
• Rawlings ND, Barrett AJ, Bateman A. MEROPS: the peptidase database. Nucleic Acids Res. 2010;38:D227–33. doi:10.1093/nar/gkp971.
   PubMed Web of Science ®Google Scholar
• Lopez-Otin C, Bond JS. Proteases: multifunctional enzymes in life and disease. J Biol Chem. 2008;283:30433–30437. doi:10.1074/jbc.R800035200.
   PubMed Web of Science ®Google Scholar
• Vergnolle N. Protease inhibition as new therapeutic strategy for GI diseases. Gut. 2016;65:1215–1224. doi:10.1136/gutjnl-2015-309147.
   PubMed Web of Science ®Google Scholar
• Tripathi LP, Sowdhamini R. Genome-wide survey of prokaryotic serine proteases: analysis of distribution and domain architectures of five serine protease families in prokaryotes. BMC Genomics. 2008;9:549. doi:10.1186/1471-2164-9-549.
   PubMed Web of Science ®Google Scholar
• Raju RM, Goldberg AL, Rubin EJ. Bacterial proteolytic complexes as therapeutic targets. Nat Rev Drug Discov. 2012;11:777–789. doi:10.1038/nrd3846.
   PubMed Web of Science ®Google Scholar
• Culp E, Wright GD. Bacterial proteases, untapped antimicrobial drug targets. J Antibiot (Tokyo). 2017;70:366–377. doi:10.1038/ja.2016.138.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Lupas AN, Finley D. Structure and mechanism of ATP-dependent proteases. Curr Opin Chem Biol. 1999;3:584–591. doi:10.1016/S1367-5931(99)00013-7.
   PubMed Web of Science ®Google Scholar
• Motta JP, Bermudez-Humaran LG, Deraison C, Martin L, Rolland C, Rousset P, Boue J, Dietrich G, Chapman K, Kharrat P, et al. Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci Transl Med. 2012;4:158ra44. doi:10.1126/scitranslmed.3004212.
   Web of Science ®Google Scholar
• Dabek M, Ferrier L, Roka R, Gecse K, Annahazi A, Moreau J, Escourrou J, Cartier C, Chaumaz G, Leveque M, et al. Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis. Am J Pathol. 2009;175:207–214. doi:10.2353/ajpath.2009.080986.
   PubMed Web of Science ®Google Scholar
• Motta JP, Rolland C, Edir A, Florence AC, Sagnat D, Bonnart C, Rousset P, Guiraud L, Quaranta-Nicaise M, Mas E, et al. Epithelial production of elastase is increased in inflammatory bowel disease and causes mucosal inflammation. Mucosal Immunol. 2021;14:667–678. doi:10.1038/s41385-021-00375-w.
   PubMed Web of Science ®Google Scholar
• Motta JP, Magne L, Descamps D, Rolland C, Squarzoni-Dale C, Rousset P, Martin L, Cenac N, Balloy V, Huerre M, et al. Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis. Gastroenterology. 2011;140:1272–1282. doi:10.1053/j.gastro.2010.12.050.
   PubMed Web of Science ®Google Scholar
• Ceuleers H, Hanning N, Heirbaut J, Van Remoortel S, Joossens J, Van Der Veken P, Francque SM, De Bruyn M, Lambeir A-M, De Man JG, et al. Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome. Br J Pharmacol. 2018;175:3516–3533. doi:10.1111/bph.14396.
   PubMed Web of Science ®Google Scholar
• Galipeau HJ, Caminero A, Turpin W, Bermudez-Brito M, Santiago A, Libertucci J, Constante M, Raygoza Garay JA, Rueda G, Armstrong S, et al. Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis. Gastroenterology. 2021;160:1532–1545. doi:10.1053/j.gastro.2020.12.004.
   PubMed Web of Science ®Google Scholar
• Mills RH, Dulai PS, Vazquez-Baeza Y, Sauceda C, Daniel N, Gerner RR, Batachari LE, Malfavon M, Zhu Q, Weldon K, et al. Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity. Nat Microbiol. 2022;7(2):262–276. doi:10.1038/s41564-021-01050-3.
   PubMed Web of Science ®Google Scholar
• Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, Kelly CP, Ahuja V, Makharia GK. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(6):823–36 e2. doi:10.1016/j.cgh.2017.06.037.
   PubMed Web of Science ®Google Scholar
• Galipeau HJ, Verdu EF. The double-edged sword of gut bacteria in celiac disease and implications for therapeutic potential. Mucosal Immunol. 2022;15:235–243. doi:10.1038/s41385-021-00479-3.
   PubMed Web of Science ®Google Scholar
• Lindfors K, Ciacci C, Kurppa K, Lundin KEA, Makharia GK, Mearin ML, Murray JA, Verdu EF, Kaukinen K. Coeliac disease. Nat Rev Dis Primers. 2019;5(1):3. doi:10.1038/s41572-018-0054-z.
   PubMed Web of Science ®Google Scholar
• Kivela L, Caminero A, Leffler DA, Pinto-Sanchez MI, Tye-Din JA, Lindfors K. Current and emerging therapies for coeliac disease. Nat Rev Gastroenterol Hepatol. 2021;18:181–195. doi:10.1038/s41575-020-00378-1.
   PubMed Web of Science ®Google Scholar
• Constante M, Libertucci J, Galipeau HJ, Szamosi JC, Rueda G, Miranda PM, Pinto-Sanchez MI, Southward CM, Rossi L, Fontes ME, et al. Biogeographic variation and functional pathways of the gut microbiota in celiac disease. Gastroenterology. 2022. doi:10.1053/j.gastro.2022.06.088.
   PubMed Web of Science ®Google Scholar
• Caminero A, Verdu EF. Celiac disease: should we care about microbes? Am J Physiol Gastrointest Liver Physiol. 2019;317:G161–G70. doi:10.1152/ajpgi.00099.2019.
   PubMed Web of Science ®Google Scholar
• Kemppainen KM, Lynch KF, Liu E, Lonnrot M, Simell V, Briese T, Koletzko S, Hagopian W, Rewers M, She J-X, et al. Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life. Clin Gastroenterol Hepatol. 2017;15:694–702 e5. doi:10.1016/j.cgh.2016.10.033.
   PubMed Web of Science ®Google Scholar
• Bernardo D, Garrote JA, Nadal I, Leon AJ, Calvo C, Fernandez-Salazar L, Blanco-Quiros A, Sanz Y, Arranz E. Is it true that coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa. Gut. 2009;58:886–887. doi:10.1136/gut.2008.167296.
   PubMed Web of Science ®Google Scholar
• Caminero A, Nistal E, Herran AR, Perez-Andres J, Ferrero MA, Vaquero Ayala L, Vivas S, Ruiz de Morales JMG, Albillos SM, Casqueiro FJ, et al. Differences in gluten metabolism among healthy volunteers, coeliac disease patients and first-degree relatives. Br J Nutr. 2015;114:1157–1167. doi:10.1017/S0007114515002767.
   PubMed Web of Science ®Google Scholar
• Caminero A, Galipeau HJ, McCarville JL, Johnston CW, Bernier SP, Russell AK, Jury J, Herran AR, Casqueiro J, Tye-Din JA, et al. Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity. Gastroenterology. 2016;151:670–683. doi:10.1053/j.gastro.2016.06.041.
   PubMed Web of Science ®Google Scholar
• McCarville JL, Dong J, Caminero A, Bermudez-Brito M, Jury J, Murray JA, et al. A commensal bifidobacterium longum strain prevents gluten-related immunopathology in mice through expression of a serine protease inhibitor. Appl Environ Microbiol. 2017;83(19):e01323-17. doi:10.1128/AEM.01323-17.
   Web of Science ®Google Scholar
• Frazer AC, Fletcher RF, Ross CA, Shaw B, Sammons HG, Schneider R. Gluten-induced enteropathy: the effect of partially digested gluten. Lancet. 1959;2:252–255. doi:10.1016/S0140-6736(59)92051-3.
   PubMed Web of Science ®Google Scholar
• Douglas AP, Peters TJ. Peptide hydrolase activity of human intestinal mucosa in adult coeliac disease. Gut. 1970;11:15–17. doi:10.1136/gut.11.1.15.
   PubMed Web of Science ®Google Scholar
• Zamakhchari M, Wei G, Dewhirst F, Lee J, Schuppan D, Oppenheim FG, Helmerhorst EJ. Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract. PLoS One. 2011;6:e24455. doi:10.1371/journal.pone.0024455.
   PubMed Web of Science ®Google Scholar
• Wei G, Darwish G, Oppenheim FG, Schuppan D, Helmerhorst EJ. Commensal bacterium rothia aeria degrades and detoxifies gluten via a highly effective subtilisin enzyme. Nutrients. 2020;12:3724. doi: 10.3390/nu12123724.
   Google Scholar
• Shan L, Marti T, Sollid LM, Gray GM, Khosla C. Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue. Biochem J. 2004;383:311–318. doi:10.1042/BJ20040907.
   PubMed Web of Science ®Google Scholar
• Pultz IS, Hill M, Vitanza JM, Wolf C, Saaby L, Liu T, Winkle P, Leffler DA. Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease. Gastroenterology. 2021;161:81–93 e3. doi:10.1053/j.gastro.2021.03.019.
   PubMed Web of Science ®Google Scholar
• Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C. Structural basis for gluten intolerance in celiac sprue. Science. 2002;297:2275–2279. doi:10.1126/science.1074129.
   PubMed Web of Science ®Google Scholar
• Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016;S0016-5085(16): 00222-5. doi: 10.1053/j.gastro.2016.02.031.
   Web of Science ®Google Scholar
• Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrom1. Gastroenterology. 2004;126(7):1657–1664. doi:10.1053/j.gastro.2004.03.013.
   PubMed Web of Science ®Google Scholar
• Cremon C, Carini G, Wang B, Vasina V, Cogliandro RF, De Giorgio R, Stanghellini V, Grundy D, Tonini M, De Ponti F, et al. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Am J Gastroenterol. 2011;106(7):1290–1298. doi:10.1038/ajg.2011.86.
   PubMed Web of Science ®Google Scholar
• Bashashati M, Moossavi S, Cremon C, Barbaro MR, Moraveji S, Talmon G, et al. Colonic immune cells in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2018. p. 30.
   Google Scholar
• Bhattarai Y, Muniz Pedrogo DA, Kashyap PC. Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol. 2017;312:G52–G62. doi:10.1152/ajpgi.00338.2016.
   PubMed Web of Science ®Google Scholar
• Edwinson AL, Yang L, Peters S, Hanning N, Jeraldo P, Jagtap P, Simpson JB, Yang T-Y, Kumar P, Mehta S, et al. Gut microbial beta-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome. Nat Microbiol. 2022;7:680–694. doi:10.1038/s41564-022-01103-1.
   PubMed Web of Science ®Google Scholar
• Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G, Andrade-Gordon P, Steinhoff M, Barbara G, Beck P, Bunnett NW, et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest. 2007;117(3):636–647. doi:10.1172/JCI29255.
   PubMed Web of Science ®Google Scholar
• Palrasu M, Zaika E, Paulrasu K, Caspa Gokulan R, Suarez G, Que J, El-Rifai W, Peek RM, Garcia-Buitrago M, Zaika AI, et al. Helicobacter pylori pathogen inhibits cellular responses to oncogenic stress and apoptosis. PLoS Pathog. 2022;18(6):e1010628. doi:10.1371/journal.ppat.1010628.
   PubMed Web of Science ®Google Scholar
• Yamaoka Y. Mechanisms of disease: helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 2010;7:629–641. doi:10.1038/nrgastro.2010.154.
   PubMed Web of Science ®Google Scholar
• Marques MS, Costa AC, Osorio H, Pinto ML, Relvas S, Dinis-Ribeiro M, Carneiro F, Leite M, Figueiredo C. Helicobacter pylori PqqE is a new virulence factor that cleaves junctional adhesion molecule A and disrupts gastric epithelial integrity. Gut Microbes. 2021;13:1–21. doi:10.1080/19490976.2021.1921928.
   PubMed Web of Science ®Google Scholar
• Tegtmeyer N, Wessler S, Necchi V, Rohde M, Harrer A, Rau TT, Asche CI, Boehm M, Loessner H, Figueiredo C, et al. Helicobacter pylori employs a unique basolateral type IV secretion mechanism for cagA delivery. Cell Host Microbe. 2017;22(4):552–60 e5. doi:10.1016/j.chom.2017.09.005.
   PubMed Web of Science ®Google Scholar
• Ho Löwer M, Weydig C, Tegtmeyer N, Geppert T, Schröder P, Sewald N, Backert S, Schneider G, Hoy B, et al. Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E-cadherin to disrupt intercellular adhesion. EMBO Rep. 2010;11(10):798–804. doi:10.1038/embor.2010.114.
   PubMed Web of Science ®Google Scholar
• Sattar SBA, Bacterial Gastroenteritis SS. StatPearls. Treasure Island (FL). 2022
   Google Scholar
• O’Ryan M, Prado V, Pickering LK. A millennium update on pediatric diarrheal illness in the developing world. Semin Pediatr Infect Dis. 2005;16:125–136. doi:10.1053/j.spid.2005.12.008.
   PubMedGoogle Scholar
• Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, Choroszy-Krol I. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut Pathog. 2019;11:10. doi:10.1186/s13099-019-0290-0.
   PubMed Web of Science ®Google Scholar
• Ruiz-Perez F, Nataro JP. Bacterial serine proteases secreted by the autotransporter pathway: classification, specificity, and role in virulence. Cell Mol Life Sci. 2014;71:745–770. doi:10.1007/s00018-013-1355-8.
   PubMed Web of Science ®Google Scholar
• Henderson IR, Czeczulin J, Eslava C, Noriega F, Nataro JP. Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infect Immun. 1999;67:5587–5596. doi:10.1128/IAI.67.11.5587-5596.1999.
   PubMed Web of Science ®Google Scholar
• Abreu AG, Abe CM, Nunes KO, Moraes CT, Chavez-Duenas L, Navarro-Garcia F, Barbosa AS, Piazza RMF, Elias WP. The serine protease Pic as a virulence factor of atypical enteropathogenic Escherichia coli. Gut Microbes. 2016;7:115–125. doi:10.1080/19490976.2015.1136775.
   PubMed Web of Science ®Google Scholar
• Bhullar K, Zarepour M, Yu H, Yang H, Croxen M, Stahl M, et al. The serine protease autotransporter pic modulates citrobacter rodentium pathogenesis and its innate recognition by the host. Infect Immun. 2015;83:2636–2650. doi:10.1128/IAI.00025-15.
   PubMed Web of Science ®Google Scholar
• Harrington SM, Sheikh J, Henderson IR, Ruiz-Perez F, Cohen PS, Nataro JP. The Pic protease of enteroaggregative Escherichia coli promotes intestinal colonization and growth in the presence of mucin. Infect Immun. 2009;77:2465–2473. doi:10.1128/IAI.01494-08.
   PubMed Web of Science ®Google Scholar
• Maldonado-Contreras A, Birtley JR, Boll E, Zhao Y, Mumy KL, Toscano J, Ayehunie S, Reinecker H-C, Stern LJ, McCormick BA, et al. Shigella depends on SepA to destabilize the intestinal epithelial integrity via cofilin activation. Gut Microbes. 2017;8:544–560. doi:10.1080/19490976.2017.1339006.
   PubMed Web of Science ®Google Scholar
• Grys TE, Walters LL, Welch RA. Characterization of the StcE protease activity of Escherichia coli O157:H7. J Bacteriol. 2006;188:4646–4653. doi:10.1128/JB.01806-05.
   PubMed Web of Science ®Google Scholar
• Hews CL, Tran SL, Wegmann U, Brett B, Walsham ADS, Kavanaugh D, et al. The StcE metalloprotease of enterohaemorrhagic Escherichia coli reduces the inner mucus layer and promotes adherence to human colonic epithelium ex vivo. Cell Microbiol. 2017;19(6):e12717. doi: 10.1111/cmi.12717.
   Web of Science ®Google Scholar
• Grys TE, Siegel MB, Lathem WW, Welch RA. The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157: h7 to host cells. Infect Immun. 2005;73:1295–1303. doi:10.1128/IAI.73.3.1295-1303.2005.
   PubMed Web of Science ®Google Scholar
• Valeri M, Rossi Paccani S, Kasendra M, Nesta B, Serino L, Pizza M, et al. Pathogenic E. Coli Exploits SslE Mucinase Activity to Translocate through the Mucosal Barrier and Get Access to Host Cells. PLoS One. 2015;10:e0117486.
   Google Scholar
• Luo Q, Kumar P, Vickers TJ, Sheikh A, Lewis WG, Rasko DA, Sistrunk J, Fleckenstein JM. Enterotoxigenic Escherichia coli secretes a highly conserved mucin-degrading metalloprotease to effectively engage intestinal epithelial cells. Infect Immun. 2014;82:509–521. doi:10.1128/IAI.01106-13.
   PubMed Web of Science ®Google Scholar
• Nesta B, Valeri M, Spagnuolo A, Rosini R, Mora M, Donato P, Alteri CJ, Del Vecchio M, Buccato S, Pezzicoli A, et al. SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strains. PLoS Pathog. 2014;10:e1004124. doi:10.1371/journal.ppat.1004124.
   PubMed Web of Science ®Google Scholar
• Sharafutdinov I, Tegtmeyer N, Musken M, Backert S. Campylobacter jejuni serine protease HtrA Induces paracellular transmigration of microbiota across polarized intestinal epithelial cells. Biomolecules. 2022;12(4):521. doi: 10.3390/biom12040521.
   Google Scholar
• Brondsted L, Andersen MT, Parker M, Jorgensen K, Ingmer H. The HtrA protease of Campylobacter jejuni is required for heat and oxygen tolerance and for optimal interaction with human epithelial cells. Appl Environ Microbiol. 2005;71:3205–3212. doi:10.1128/AEM.71.6.3205-3212.2005.
   PubMed Web of Science ®Google Scholar
• Lewis C, Skovierova H, Rowley G, Rezuchova B, Homerova D, Stevenson A, Spencer J, Farn J, Kormanec J, Roberts M, et al. Salmonella enterica Serovar Typhimurium HtrA: regulation of expression and role of the chaperone and protease activities during infection. Microbiology (Reading). 2009;155:873–881. doi:10.1099/mic.0.023754-0.
   PubMed Web of Science ®Google Scholar
• Baker-Austin C, Oliver JD, Alam M, Ali A, Waldor MK, Qadri F, et al. Vibrio spp. Infections. Nat Rev Dis Primers. 2018;4:8.
   PubMed Web of Science ®Google Scholar
• Wu Z, Nybom P, Magnusson KE. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell Microbiol. 2000;2:11–17. doi:10.1046/j.1462-5822.2000.00025.x.
   PubMed Web of Science ®Google Scholar
• Kordus SL, Thomas AK, Lacy DB. Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics. Nat Rev Microbiol. 2022;20:285–298. doi:10.1038/s41579-021-00660-2.
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559–563. doi:10.1038/nature12820.
   PubMed Web of Science ®Google Scholar
• Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334:105–108. doi:10.1126/science.1208344.
   PubMed Web of Science ®Google Scholar
• Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17:223–237. doi:10.1038/s41575-019-0258-z.
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Simren M, Bercik P. Evidence-based and mechanistic insights into exclusion diets for IBS. Nat Rev Gastroenterol Hepatol. 2020;17:406–413. doi:10.1038/s41575-020-0270-3.
   PubMed Web of Science ®Google Scholar
• McIntosh K, Reed DE, Schneider T, Dang F, Keshteli AH, De Palma G, Madsen K, Bercik P, Vanner S. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut. 2017;66:1241–1251. doi:10.1136/gutjnl-2015-311339.
   PubMed Web of Science ®Google Scholar
• Sasson AN, Ananthakrishnan AN, Raman M. Diet in treatment of inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2021;19:425–35 e3. doi:10.1016/j.cgh.2019.11.054.
   PubMed Web of Science ®Google Scholar
• Junker Y, Zeissig S, Kim SJ, Barisani D, Wieser H, Leffler DA, et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med. 2012;209:2395–2408. doi:10.1084/jem.20102660.
   PubMed Web of Science ®Google Scholar
• Koppel N, Maini Rekdal V, Balskus EP. Chemical transformation of xenobiotics by the human gut microbiota. Science. 2017;356(6344):eaag2770. doi: 10.1126/science.aag2770.
   Google Scholar
• Caminero A, Meisel M, Jabri B, Verdu EF. Mechanisms by which gut microorganisms influence food sensitivities. Nat Rev Gastroenterol Hepatol. 2019;16:7–18. doi:10.1038/s41575-018-0064-z.
   PubMed Web of Science ®Google Scholar
• Caminero A, Verdu EF. Metabolism of wheat proteins by intestinal microbes: implications for wheat related disorders. Gastroenterol Hepatol. 2019;42:449–457. doi:10.1016/j.gastrohep.2019.04.001.
   PubMed Web of Science ®Google Scholar
• Herran AR, Perez-Andres J, Caminero A, Nistal E, Vivas S. Ruiz de Morales JM, et al. Gluten-degrading Bacteria are Present in the Human Small Intestine of Healthy Volunteers and Celiac Patients. Res Microbiol. 2017;168:673–684.
   Google Scholar
• Caminero A, Herran AR, Nistal E, Perez-Andres J, Vaquero L, Vivas S, Ruiz de Morales JMG, Albillos SM, Casqueiro J. Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease. FEMS Microbiol Ecol. 2014;88:309–319. doi:10.1111/1574-6941.12295.
   PubMed Web of Science ®Google Scholar
• Tian N, Faller L, Leffler DA, Kelly CP, Hansen J, Bosch JA, et al. Salivary gluten degradation and oral microbial profiles in healthy individuals and celiac disease patients. Appl Environ Microbiol. 2017;83(6):e03330-16. doi: 10.1128/AEM.03330-16.
   Web of Science ®Google Scholar
• Tian N, Wei G, Schuppan D, Helmerhorst EJ. Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease. Am J Physiol Gastrointest Liver Physiol. 2014;307:G769–76.
   PubMed Web of Science ®Google Scholar
• Bellinghausen I, Weigmann B, Zevallos V, Maxeiner J, Reissig S, Waisman A, Schuppan D, Saloga J. Wheat amylase-trypsin inhibitors exacerbate intestinal and airway allergic immune responses in humanized mice. J Allergy Clin Immunol. 2019;143(1):201–12 e4. doi:10.1016/j.jaci.2018.02.041.
   PubMed Web of Science ®Google Scholar
• Zevallos VF, Raker V, Tenzer S, Jimenez-Calvente C, Ashfaq-Khan M, Russel N, Pickert G, Schild H, Steinbrink K, Schuppan D, et al. Nutritional wheat amylase-trypsin inhibitors promote intestinal inflammation via activation of myeloid cells. Gastroenterology. 2017;152(5):1100–13 e12. doi:10.1053/j.gastro.2016.12.006.
   PubMed Web of Science ®Google Scholar
• Caminero A, McCarville JL, Zevallos VF, Pigrau M, Yu XB, Jury J, Galipeau HJ, Clarizio AV, Casqueiro J, Murray JA, et al. Lactobacilli degrade wheat amylase trypsin inhibitors to reduce intestinal dysfunction induced by immunogenic wheat proteins. Gastroenterology. 2019;156(8):2266–2280. doi:10.1053/j.gastro.2019.02.028.
   PubMed Web of Science ®Google Scholar
• Hughes R, Kurth MJ, McGilligan V, McGlynn H, Rowland I. Effect of colonic bacterial metabolites on Caco-2 cell paracellular permeability in vitro. Nutr Cancer. 2008;60:259–266. doi:10.1080/01635580701649644.
   PubMed Web of Science ®Google Scholar
• Gill PA, Inniss S, Kumagai T, Rahman FZ, Smith AM. The role of diet and gut microbiota in regulating gastrointestinal and inflammatory disease. Front Immunol. 2022;13:866059. doi:10.3389/fimmu.2022.866059.
   PubMed Web of Science ®Google Scholar
• Bermudez-Martin P, Becker JAJ, Caramello N, Fernandez SP, Costa-Campos R, Canaguier J, Barbosa S, Martinez-Gili L, Myridakis A, Dumas M-E, et al. The microbial metabolite p-Cresol induces autistic-like behaviors in mice by remodeling the gut microbiota. Microbiome. 2021;9(1):157. doi:10.1186/s40168-021-01103-z.
   PubMed Web of Science ®Google Scholar
• Jeffery IB, Das A, O’Herlihy E, Coughlan S, Cisek K, Moore M, Bradley F, Carty T, Pradhan M, Dwibedi C, et al. Differences in fecal microbiomes and metabolomes of people with vs without irritable bowel syndrome and bile acid malabsorption. Gastroenterology. 2020;158(4):1016–28 e8. doi:10.1053/j.gastro.2019.11.301.
   PubMed Web of Science ®Google Scholar
• Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli J, Chow J, Reisman S, Petrosino J, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155(7):1451–1463. doi:10.1016/j.cell.2013.11.024.
   PubMed Web of Science ®Google Scholar
• Needham BD, Funabashi M, Adame MD, Wang Z, Boktor JC, Haney J, Wu W-L, Rabut C, Ladinsky MS, Hwang S-J, et al. A gut-derived metabolite alters brain activity and anxiety behaviour in mice. Nature. 2022;602(7898):647–653. doi:10.1038/s41586-022-04396-8.
   PubMed Web of Science ®Google Scholar
• Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, Martin F-P, Cominetti O, Welsh C, Rieder A, et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology. 2017;153(2):448–59 e8. doi:10.1053/j.gastro.2017.05.003.
   PubMed Web of Science ®Google Scholar
• Miller TW, Wang EA, Gould S, Stein EV, Kaur S, Lim L, Amarnath S, Fowler DH, Roberts DD. Hydrogen sulfide is an endogenous potentiator of T cell activation. J Biol Chem. 2012;287(6):4211–4221. doi:10.1074/jbc.M111.307819.
   PubMed Web of Science ®Google Scholar
• Guo FF, Yu TC, Hong J, Fang JY. Emerging roles of hydrogen sulfide in inflammatory and neoplastic colonic diseases. Front Physiol. 2016;7:156. doi:10.3389/fphys.2016.00156.
   PubMed Web of Science ®Google Scholar
• Wallace JL, Wang R. Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter. Nat Rev Drug Discov. 2015;14:329–345. doi:10.1038/nrd4433.
   PubMed Web of Science ®Google Scholar
• Barik S, Vanderschueren D, Antonio L. The uniqueness of tryptophan in biology: properties, metabolism, interactions and localization in proteins. Int J Mol Sci. 2020;22:21. doi:10.3390/ijms22010021.
   PubMedGoogle Scholar
• Cheng J, Shah YM, Gonzalez FJ. Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol Sci. 2012;33:323–330. doi:10.1016/j.tips.2012.03.003.
   PubMed Web of Science ®Google Scholar
• Monteleone I, Rizzo A, Sarra M, Sica G, Sileri P, Biancone L, MacDonald TT, Pallone F, Monteleone G. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology. 2011;141(237–48):48 e1. doi:10.1053/j.gastro.2011.04.007.
   Google Scholar
• Lamas B, Richard ML, Leducq V, Pham HP, Michel ML, Da Costa G, Bridonneau C, Jegou S, Hoffmann TW, Natividad,J M., et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med 2016; 22:598–605. 10.1038/nm.4102
   PubMed Web of Science ®Google Scholar
• Lamas B, Hernandez-Galan L, Galipeau HJ, Constante M, Clarizio A, Jury J, et al. Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation. Sci Transl Med. 2020;12(566):eaba0624. doi: 10.1126/scitranslmed.aba0624.
   Web of Science ®Google Scholar
• Martens EC, Neumann M, Desai MS. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat Rev Microbiol. 2018;16:457–470. doi:10.1038/s41579-018-0036-x.
   PubMed Web of Science ®Google Scholar
• Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Büller HA, Dekker J, Van Seuningen I, Renes IB, et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006;131:117–129. doi:10.1053/j.gastro.2006.04.020.
   PubMed Web of Science ®Google Scholar
• Tytgat KM, Opdam FJ, Einerhand AW, Buller HA, Dekker J. MUC2 is the prominent colonic mucin expressed in ulcerative colitis. Gut. 1996;38:554–563. doi:10.1136/gut.38.4.554.
   PubMed Web of Science ®Google Scholar
• Buisine MP, Desreumaux P, Leteurtre E, Copin MC, Colombel JF, Porchet N, et al. Mucin gene expression in intestinal epithelial cells in Crohn’s disease. Gut. 2001;49:544–551. doi:10.1136/gut.49.4.544.
   PubMed Web of Science ®Google Scholar
• Johansson ME, Hansson GC. Immunological aspects of intestinal mucus and mucins. Nat Rev Immunol. 2016;16:639–649. doi:10.1038/nri.2016.88.
   PubMed Web of Science ®Google Scholar
• Variyam EP, Hoskins LC. Mucin degradation in human colon ecosystems. Degradation of Hog Gastric Mucin by Fecal Extracts and Fecal Cultures. Gastroenterology. 1981;81:751–758.
   Google Scholar
• Macfarlane GT, Hay S, Gibson GR. Influence of mucin on glycosidase, protease and arylamidase activities of human gut bacteria grown in a 3-stage continuous culture system. J Appl Bacteriol. 1989;66:407–417. doi:10.1111/j.1365-2672.1989.tb05110.x.
   PubMedGoogle Scholar
• Pruteanu M, Hyland NP, Clarke DJ, Kiely B, Shanahan F. Degradation of the extracellular matrix components by bacterial-derived metalloproteases: implications for inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:1189–1200. doi:10.1002/ibd.21475.
   PubMed Web of Science ®Google Scholar
• Nakjang S, Ndeh DA, Wipat A, Bolam DN, Hirt RP, Permyakov EA. A novel extracellular metallopeptidase domain shared by animal host-associated mutualistic and pathogenic microbes. PLoS One. 2012;7:e30287. doi:10.1371/journal.pone.0030287.
   PubMed Web of Science ®Google Scholar
• Noach I, Ficko-Blean E, Pluvinage B, Stuart C, Jenkins ML, Brochu D, Buenbrazo N, Wakarchuk W, Burke JE, Gilbert M, et al. Recognition of protein-linked glycans as a determinant of peptidase activity. Proc Natl Acad Sci U S A. 2017;114(5):E679–E88. doi:10.1073/pnas.1615141114.
   PubMed Web of Science ®Google Scholar
• Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167(5):1339–53 e21. doi:10.1016/j.cell.2016.10.043.
   PubMed Web of Science ®Google Scholar
• Odenwald MA, Turner JR. The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol. 2017;14:9–21. doi:10.1038/nrgastro.2016.169.
   PubMed Web of Science ®Google Scholar
• Kriaa A, Jablaoui A, Rhimi S, Soussou S, Mkaouar H, Mariaule V, et al. SP-1, a serine protease from the gut microbiota, influences colitis and drives intestinal dysbiosis in mice. In: Cells. 2021;10:2658. doi: 10.3390/cells10102658.
   Google Scholar
• Scudamore CL, Jepson MA, Hirst BH, Miller HR, Miller P. The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin. Eur J Cell Biol. 1998;75:321–330. doi:10.1016/S0171-9335(98)80065-4.
   PubMed Web of Science ®Google Scholar
• Steck N, Hoffmann M, Sava IG, Kim SC, Hahne H, Tonkonogy SL, Mair K, Krueger D, Pruteanu M, Shanahan F, et al. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology. 2011;141(3):959–971. doi:10.1053/j.gastro.2011.05.035.
   PubMed Web of Science ®Google Scholar
• Golovkine G, Faudry E, Bouillot S, Voulhoux R, Attree I, Huber P, Kazmierczak BI. VE-cadherin cleavage by LasB protease from Pseudomonas aeruginosa facilitates type III secretion system toxicity in endothelial cells. PLoS Pathog. 2014;10(3):e1003939. doi:10.1371/journal.ppat.1003939.
   PubMed Web of Science ®Google Scholar
• Guttman JA, Finlay BB. Tight junctions as targets of infectious agents. Biochim Biophys Acta. 2009;1788:832–841. doi:10.1016/j.bbamem.2008.10.028.
   PubMed Web of Science ®Google Scholar
• Cenac N, Chin AC, Garcia-Villar R, Salvador-Cartier C, Ferrier L, Vergnolle N, Buret AG, Fioramonti J, Bueno L. PART 2 activation alters colonic paracellular permeability in mice via IFN-γ-dependent and -independent pathways. J Physiol. 2004;558:913–925. doi:10.1113/jphysiol.2004.061721.
   PubMed Web of Science ®Google Scholar
• Cottrell GS, Amadesi S, Pikios S, Camerer E, Willardsen JA, Murphy BR, Caughey GH, Wolters PJ, Coughlin SR, Peterson A, et al. Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis. Gastroenterology. 2007;132(7):2422–2437. doi:10.1053/j.gastro.2007.03.101.
   PubMed Web of Science ®Google Scholar
• Peach CJ, Edgington-Mitchell LE, Bunnett NW, Schmidt BL. Protease-Activated receptors in health and disease. Physiol Rev. 2022. doi:10.1152/physrev.00044.2021.
   PubMed Web of Science ®Google Scholar
• Adams MN, Ramachandran R, Yau MK, Suen JY, Fairlie DP, Hollenberg MD, Hooper JD. Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther. 2011;130:248–282. doi:10.1016/j.pharmthera.2011.01.003.
   PubMed Web of Science ®Google Scholar
• Darmoul D, Gratio V, Devaud H, Peiretti F, Laburthe M. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol Cancer Res. 2004;2:514–522. doi:10.1158/1541-7786.514.2.9.
   PubMed Web of Science ®Google Scholar
• Cenac N, Garcia-Villar R, Ferrier L, Larauche M, Vergnolle N, Bunnett NW, Coelho A-M, Fioramonti J, Bueno L. Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability. J Immunol. 2003;170(8):4296–4300. doi:10.4049/jimmunol.170.8.4296.
   PubMed Web of Science ®Google Scholar
• Chin AC, Vergnolle N, MacNaughton WK, Wallace JL, Hollenberg MD, Buret AG. Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability. Proc Natl Acad Sci U S A. 2003;100:11104–11109. doi:10.1073/pnas.1831452100.
   PubMed Web of Science ®Google Scholar
• Jimenez-Vargas NN, Pattison LA, Zhao P, Lieu T, Latorre R, Jensen DD, Castro J, Aurelio L, Le GT, Flynn B, et al. Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome. Proc Natl Acad Sci U S A. 2018;115:E7438–E47. doi:10.1073/pnas.1721891115.
   PubMed Web of Science ®Google Scholar
• Kim JA, Choi SC, Yun KJ, Kim DK, Han MK, Seo GS, Yeom -J-J, Kim T-H, Nah Y-H, Lee Y-M, et al. Expression of protease-activated receptor 2 in ulcerative colitis. Inflamm Bowel Dis. 2003;9:224–229. doi:10.1097/00054725-200307000-00002.
   PubMed Web of Science ®Google Scholar
• Dulon S, Leduc D, Cottrell GS, D’Alayer J, Hansen KK, Bunnett NW, Hollenberg MD, Pidard D, Chignard M. Pseudomonas aeruginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells. Am J Respir Cell Mol Biol. 2005;32(5):411–419. doi:10.1165/rcmb.2004-0274OC.
   PubMed Web of Science ®Google Scholar
• Maharshak N, Huh EY, Paiboonrungruang C, Shanahan M, Thurlow L, Herzog J, Djukic Z, Orlando R, Pawlinski R, Ellermann M, et al. Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2. Infect Immun. 2015;83(7):2762–2770. doi:10.1128/IAI.00425-15.
   PubMed Web of Science ®Google Scholar
• Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, Mackie EJ, Pike RN. Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett. 1998;435:45–48. doi:10.1016/S0014-5793(98)01036-9.
   PubMed Web of Science ®Google Scholar
• Parmely M, Gale A, Clabaugh M, Horvat R, Zhou WW. Proteolytic inactivation of cytokines by Pseudomonas aeruginosa. Infect Immun. 1990;58:3009–3014. doi:10.1128/iai.58.9.3009-3014.1990.
   PubMed Web of Science ®Google Scholar
• Theander TG, Kharazmi A, Pedersen BK, Christensen LD, Tvede N, Poulsen LK, Odum N, Svenson M, Bendtzen K. Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases. Infect Immun. 1988;56:1673–1677. doi:10.1128/iai.56.7.1673-1677.1988.
   PubMed Web of Science ®Google Scholar
• Mintz CS, Miller RD, Gutgsell NS, Malek T. Legionella pneumophila protease inactivates interleukin-2 and cleaves CD4 on human T cells. Infect Immun. 1993;61:3416–3421. doi:10.1128/iai.61.8.3416-3421.1993.
   PubMed Web of Science ®Google Scholar
• Fletcher J, Nair S, Poole S, Henderson B, Wilson M. Cytokine degradation by biofilms of Porphyromonas gingivalis. Curr Microbiol. 1998;36:216–219. doi:10.1007/s002849900297.
   PubMed Web of Science ®Google Scholar
• Janoff EN, Rubins JB, Fasching C, Charboneau D, Rahkola JT, Plaut AG, Weiser JN. Pneumococcal IgA1 protease subverts specific protection by human IgA1. Mucosal Immunol. 2014;7(2):249–256. doi:10.1038/mi.2013.41.
   PubMed Web of Science ®Google Scholar
• Woof JM, Russell MW. Structure and function relationships in IgA. Mucosal Immunol. 2011;4:590–597. doi:10.1038/mi.2011.39.
   PubMed Web of Science ®Google Scholar
• Moon C, Baldridge MT, Wallace MA, Burnham DCA, Virgin HW, Stappenbeck TS. Vertically transmitted faecal IgA levels determine extra-chromosomal phenotypic variation. Nature. 2015;521:90–93. doi:10.1038/nature14139.
   PubMed Web of Science ®Google Scholar
• Kayssi A, Amadesi S, Bautista F, Bunnett NW, Vanner S. Mechanisms of protease-activated receptor 2-evoked hyperexcitability of nociceptive neurons innervating the mouse colon. J Physiol. 2007;580:977–991. doi:10.1113/jphysiol.2006.126599.
   PubMed Web of Science ®Google Scholar
• Reed DE, Barajas-Lopez C, Cottrell G, Velazquez-Rocha S, Dery O, Grady EF, Bunnett NW, Vanner SJ. Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of Guinea-pig submucosal neurons. J Physiol. 2003;547:531–542. doi:10.1113/jphysiol.2002.032011.
   PubMed Web of Science ®Google Scholar
• Valdez-Morales EE, Overington J, Guerrero-Alba R, Ochoa-Cortes F, Ibeakanma CO, Spreadbury I, Bunnett NW, Beyak M, Vanner SJ. Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2. Am J Gastroenterol. 2013;108(10):1634–1643. doi:10.1038/ajg.2013.241.
   PubMed Web of Science ®Google Scholar
• Cattaruzza F, Lyo V, Jones E, Pham D, Hawkins J, Kirkwood K, Valdez–Morales E, Ibeakanma C, Vanner SJ, Bogyo M, et al. Cathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR2-dependent mechanism in mice. Gastroenterology. 2011;141(1864–745):e1–3. doi:10.1053/j.gastro.2011.07.035.
   PubMedGoogle Scholar
• Karanjia R, Spreadbury I, Bautista-Cruz F, Tsang ME, Vanner S. Activation of protease-activated receptor-4 inhibits the intrinsic excitability of colonic dorsal root ganglia neurons. Neurogastroenterol Motil. 2009;21:1218–1221. doi:10.1111/j.1365-2982.2009.01353.x.
   PubMed Web of Science ®Google Scholar
• Auge C, Balz-Hara D, Steinhoff M, Vergnolle N, Cenac N. Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity. Neurogastroenterol Motil. 2009;21:1189-e107. doi: 10.1111/j.1365-2982.2009.01310.x.
   Web of Science ®Google Scholar
• Annahazi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztoczy A, Roka R, Molnár T, Theodorou V, Wittmann T, Bueno L, et al. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Pain. 2009;144(1):209–217. doi:10.1016/j.pain.2009.04.017.
   PubMed Web of Science ®Google Scholar
• Annahazi A, Ferrier L, Bezirard V, Leveque M, Eutamene H, Ait-Belgnaoui A, Coëffier M, Ducrotté P, Róka R, Inczefi O, et al. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS. Am J Gastroenterol. 2013;108(8):1322–1331. doi:10.1038/ajg.2013.152.
   PubMed Web of Science ®Google Scholar
• Miquel S, Martin R, Lashermes A, Gillet M, Meleine M, Gelot A, Eschalier A, Ardid D, Bermúdez-Humarán LG, Sokol H, et al. Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models. Sci Rep. 2016;6(1):19399. doi:10.1038/srep19399.
   PubMedGoogle Scholar
• Azghani AO, Gray LD, Johnson AR. A bacterial protease perturbs the paracellular barrier function of transporting epithelial monolayers in culture. Infect Immun. 1993;61:2681–2686. doi:10.1128/iai.61.6.2681-2686.1993.
   PubMed Web of Science ®Google Scholar
• Pinto-Lopes P, Melo F, Afonso J, Pinto-Lopes R, Rocha C, Melo D, Macedo G, Dias CC, Carneiro F, Magro F, et al. Fecal dipeptidyl peptidase-4: an emergent biomarker in inflammatory bowel disease. Clin Transl Gastroenterol. 2021;12(3):e00320. doi:10.14309/ctg.0000000000000320.
   PubMed Web of Science ®Google Scholar
• Devani M, Cugno M, Vecchi M, Ferrero S, Di Berardino F, Avesani EC, Franchis R, Colman RW. Kallikrein-kinin system activation in Crohn’s disease: differences in intestinal and systemic markers. Am J Gastroenterol. 2002;97:2026–2032. doi:10.1111/j.1572-0241.2002.05919.x.
   PubMed Web of Science ®Google Scholar